Accordingly, treatment with STAT3 inhibitor, XZH-5, caused suppression of BCL-2, BCL-XL, and Survivin, and resulted in increased apoptosis in rhabdomyosarcoma cells [110]. Here, BCL2 is linked to rhabdomyosarcoma.